{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:50:05Z","timestamp":1758120605952,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009448","name":"Universit\u00e0 degli Studi della Campania Luigi Vanvitelli","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009448","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Sickle cell disease (SCD) is a global health problem causing premature deaths and preventable severe chronic complications. A priority goal to improve outcomes both in the short and long term is the screening for early diagnosis and access to specialized care. In Italy, as in other countries, no systematic national screening program is available. A regional pilot project was developed with the aim to screen 1000 children at risk of SCD in Italy. Primary care paediatricians received point-of-care tests (POCTs) to detect abnormal haemoglobin (Hb) to be offered to children regularly followed at their own clinics. Children positive to the POCT were referred to the regional paediatric specialized centre for diagnosis confirmation and follow up. Among 1000 at risk children screened, 85 (8,5%) tested positive for an abnormal Hb. HbS trait was reported in  69\u00a0(7%) children, HbC trait in 13 (1,3%) and SCD was diagnosed in 3 (0,3% overall; 0,56% in African background) children. African family background was the most affected by sickle mutations and all children with SCD had African ancestry. Only 56\/259 (22%) primary care paediatricians invited but 20\/21 (95%) reception centres adhered to the pilot screening project.<\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>: A screening program for SCD performed by the primary care paediatricians is feasible and relatively easy to organize. SCD affects mainly children with African family background and the scarce adherence of primary care paediatricians, in contrast to the high adhesion of charitable institutions, outlines the need for a mandatory screening for SCD, and improved awareness among health care providers.\n<jats:table-wrap>\n              <jats:table>\n                <jats:tbody>\n                  <jats:tr>\n                    <jats:td align=\"left\">\n                      <jats:bold>What is Known:<\/jats:bold>\u2022 <jats:italic>Sickle Cell Disease (SCD) is a serious global health problem that requires management in specialized centres from the first months of life<\/jats:italic>.\u2022 <jats:italic>In the absence of neonatal screening for SCD, primary health care settings represent a feasible and costeffective approach for early disease detection<\/jats:italic>.<\/jats:td>\n                  <\/jats:tr>\n                  <jats:tr>\n                    <jats:td align=\"left\">\n                      <jats:bold>What is New:<\/jats:bold>\u2022 <jats:italic>In Italy, screening for SCD performed by primary care pediatricians detected a hemoglobin variant in 8.5% children, with a disease prevalence of 0.3% in the whole population and 0.56% in children with African family background<\/jats:italic>.\u2022 <jats:italic>The poor adherence of paediatricians to the voluntary screening for SCD highlights the need for legislative interventions and training activities to ensure early diagnosis and rapid access to care for all children affected by SCD<\/jats:italic>.<\/jats:td>\n                  <\/jats:tr>\n                <\/jats:tbody>\n              <\/jats:table>\n            <\/jats:table-wrap>\n          <\/jats:p>","DOI":"10.1007\/s00431-025-05988-y","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T18:49:24Z","timestamp":1738090164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening for sickle cell disease by point-of-care tests in Italy: pilot study on 1000 at risk children"],"prefix":"10.1007","volume":"184","author":[{"given":"Maddalena","family":"Casale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Scianguetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Pinfildi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Vallefuoco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Capellupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silverio","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"5988_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR (2017) Sickle cell disease. Lancet 390:311\u2013323","journal-title":"Lancet"},{"key":"5988_CR2","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","volume":"10","author":"GBDSCD Collaborators","year":"2023","unstructured":"Collaborators GBDSCD (2023) Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol 10:e585\u2013e599","journal-title":"Lancet Haematol"},{"key":"5988_CR3","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1182\/blood-2018-09-876508","volume":"133","author":"L De Franceschi","year":"2019","unstructured":"De Franceschi L, Lux C, Piel FB, Gianesin B, Bonetti F, Casale M, Graziadei G, Lisi R, Pinto V, Putti MC, Rigano P, Rosso R, Russo G, Spadola V, Pulvirenti C, Rizzi M, Mazzi F, Ruffo G, Forni GL (2019) Access to emergency departments for acute events and identification of sickle cell disease in refugees. Blood 133:2100\u20132103","journal-title":"Blood"},{"key":"5988_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13052-021-01109-1","volume":"47","author":"R Colombatti","year":"2021","unstructured":"Colombatti R, Casale M, Russo G (2021) Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority. Ital J Pediatr 47:163","journal-title":"Ital J Pediatr"},{"key":"5988_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13023-019-1099-0","volume":"14","author":"G Russo","year":"2019","unstructured":"Russo G, De Franceschi L, Colombatti R, Rigano P, Perrotta S, Voi V, Palazzi G, Fidone C, Quota A, Graziadei G, Pietrangelo A, Pinto V, Ruffo GB, Sorrentino F, Venturelli D, Casale M, Ferrara F, Sainati L, Cappellini MD, Piga A, Maggio A, Forni GL (2019) Current challenges in the management of patients with sickle cell disease - a report of the Italian experience. Orphanet J Rare Dis 14:120","journal-title":"Orphanet J Rare Dis"},{"key":"5988_CR6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/bjh.19084","volume":"204","author":"V Munaretto","year":"2024","unstructured":"Munaretto V, Corti P, Bertoni E, Tripodi SI, Guerzoni ME, Cesaro S, Arcioni F, Piccolo C, Mina T, Zecca M, Cuzzubbo D, Casale M, Palazzi G, Notarangelo LD, Masera N, Samperi P, Perrotta S, Russo G, Sainati L, Colombatti R (2024) Acute chest syndrome in children with sickle cell disease: data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system. Br J Haematol 204:1061\u20131066","journal-title":"Br J Haematol"},{"key":"5988_CR7","unstructured":"(2006) WHO Report A59\/9 on Sickle Cell Anemia. http:\/\/www.who.int\/gb\/ebwha\/pdf_files\/WHA59-REC1\/e\/WHA59_2006_REC1-en.pdf. Accessed Nov 2024"},{"key":"5988_CR8","unstructured":"(2008) UN Resolution A\/63\/L.63 \u201cRecognition of sickle-cell anaemia as a public health problem\u201d. http:\/\/www.un.org\/News\/Press\/docs\/2008\/ga10803.doc.html. Accessed Nov 2024"},{"key":"5988_CR9","doi-asserted-by":"publisher","first-page":"e27657","DOI":"10.1002\/pbc.27657","volume":"66","author":"R Colombatti","year":"2019","unstructured":"Colombatti R, Martella M, Cattaneo L, Viola G, Cappellari A, Bergamo C, Azzena S, Schiavon S, Baraldi E, Dalla Barba B, Trafojer U, Corti P, Uggeri M, Tagliabue PE, Zorloni C, Bracchi M, Biondi A, Basso G, Masera N, Sainati L (2019) Results of a multicenter universal newborn screening program for sickle cell disease in Italy: a call to action. Pediatr Blood Cancer 66:e27657","journal-title":"Pediatr Blood Cancer"},{"key":"5988_CR10","first-page":"346","volume":"12","author":"D Venturelli","year":"2014","unstructured":"Venturelli D, Lodi M, Palazzi G, Bergonzini G, Doretto G, Zini A, Monica C, Cano MC, Ilaria M, Montagnani G, Paolucci P (2014) Sickle cell disease in areas of immigration of high-risk populations: a low cost and reproducible method of screening in northern Italy. Blood Transfus 12:346\u2013351","journal-title":"Blood Transfus"},{"key":"5988_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bjh.17678","volume":"196","author":"D Dexter","year":"2022","unstructured":"Dexter D, McGann PT (2022) Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease. Br J Haematol 196:63\u201369","journal-title":"Br J Haematol"},{"issue":"1","key":"5988_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/jcm9010044","volume":"9","author":"BPD Inusa","year":"2019","unstructured":"Inusa BPD, Sainati L, MacMahon C, Colombatti R, Casale M, Perrotta S, Rampazzo P, Hemmaway C, Padayachee ST (2019) An educational study promoting the delivery of transcranial Doppler ultrasound screening in paediatric sickle cell disease: a European multi-centre perspective. J Clin Med 9(1):44. https:\/\/doi.org\/10.3390\/jcm9010044","journal-title":"J Clin Med"},{"key":"5988_CR13","doi-asserted-by":"publisher","unstructured":"Colombatti R, Palazzi G, Masera N, Notarangelo LD, Bonetti E, Samperi P, Barone A, Perrotta S, Facchini E, Miano M, Del Vecchio GC, Guerzoni ME, Corti P, Menzato F, Cesaro S, Casale M, Rigano P, Forni GL, Russo G, Sainati L, The Italian multicenter study of hydroxyurea in sickle cell anemia\u00a0Investigators\u00a0(2018) Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: results of a national multicenter survey. Pediatr Blood Cancer 65(2):e26774.\u00a0https:\/\/doi.org\/10.1002\/pbc.26774","DOI":"10.1002\/pbc.26774"},{"key":"5988_CR14","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.1016\/S2352-3026(20)30143-5","volume":"7","author":"OE Nnodu","year":"2020","unstructured":"Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB (2020) Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study. Lancet Haematol 7:e534\u2013e540","journal-title":"Lancet Haematol"},{"issue":"18","key":"5988_CR15","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.3390\/jcm11185426","volume":"11","author":"G Mandrile","year":"2022","unstructured":"Mandrile G, Barella S, Giambona A, Gigante A, Grosso M, Perrotta S, Scianguetta S, Forni GL (2022) First and second level haemoglobinopathies diagnosis: best practices of the Italian Society of Thalassemia and Haemoglobinopathies (SITE). J Clin Med 11(18):5426. https:\/\/doi.org\/10.3390\/jcm11185426","journal-title":"J Clin Med"},{"key":"5988_CR16","doi-asserted-by":"publisher","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN (2013) Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med 10:e1001484","journal-title":"PLoS Med"},{"key":"5988_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1056\/NEJMp1700101","volume":"376","author":"K Wailoo","year":"2017","unstructured":"Wailoo K (2017) Sickle cell disease - a history of progress and peril. N Engl J Med 376:805\u2013807","journal-title":"N Engl J Med"},{"key":"5988_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1750-1172-8-169","volume":"8","author":"R Colombatti","year":"2013","unstructured":"Colombatti R, Perrotta S, Samperi P, Casale M, Masera N, Palazzi G, Sainati L, Russo G, Italian Association of Pediatric Hematology-Oncology Sickle Cell Disease Working G (2013) Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood. Orphanet J Rare Dis 8:169","journal-title":"Orphanet J Rare Dis"},{"key":"5988_CR19","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1016\/j.jpeds.2016.04.048","volume":"177S","author":"G Corsello","year":"2016","unstructured":"Corsello G, Ferrara P, Chiamenti G, Nigri L, Campanozzi A, Pettoello-Mantovani M (2016) The child health care system in Italy. J Pediatr 177S:S116\u2013S126","journal-title":"J Pediatr"},{"key":"5988_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/adc.2009.165290","volume":"95","author":"M Peters","year":"2010","unstructured":"Peters M, Fijnvandraat K, van den Tweel XW, Garre FG, Giordano PC, van Wouwe JP, Pereira RR, Verkerk PH (2010) One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening. Arch Dis Child 95:822\u2013825","journal-title":"Arch Dis Child"},{"key":"5988_CR21","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1016\/S2352-3026(23)00169-2","volume":"10","author":"MA Osei","year":"2023","unstructured":"Osei MA, McGann PT (2023) Sickle cell disease: time to act on the most neglected global health problem. Lancet Haematol 10:e558\u2013e559","journal-title":"Lancet Haematol"},{"key":"5988_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S2213-8587(23)00354-6","volume":"12","author":"E Bosi","year":"2024","unstructured":"Bosi E, Catassi C (2024) Screening type 1 diabetes and celiac disease by law. Lancet Diabetes Endocrinol 12:12\u201314","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5988_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/0033354919881438","volume":"134","author":"L Lee","year":"2019","unstructured":"Lee L, Smith-Whitley K, Banks S, Puckrein G (2019) Reducing health care disparities in sickle cell disease: a review. Public Health Rep 134:599\u2013607","journal-title":"Public Health Rep"},{"key":"5988_CR24","doi-asserted-by":"publisher","first-page":"e201737","DOI":"10.1001\/jamanetworkopen.2020.1737","volume":"3","author":"F Farooq","year":"2020","unstructured":"Farooq F, Mogayzel PJ, Lanzkron S, Haywood C, Strouse JJ (2020) Comparison of US federal and foundation funding of research for sickle cell disease and cystic fibrosis and factors associated with research productivity. JAMA Netw Open 3:e201737","journal-title":"JAMA Netw Open"},{"key":"5988_CR25","doi-asserted-by":"publisher","first-page":"e057623","DOI":"10.1136\/bmjopen-2021-057623","volume":"12","author":"NM Archer","year":"2022","unstructured":"Archer NM, Inusa B, Makani J, Nkya S, Tshilolo L, Tubman VN, McGann PT, Ambrose EE, Henrich N, Spector J, Ohene-Frempong K (2022) Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries. BMJ Open 12:e057623","journal-title":"BMJ Open"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-05988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-05988-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-05988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T03:05:38Z","timestamp":1739934338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-05988-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["5988"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-05988-y","relation":{},"ISSN":["1432-1076"],"issn-type":[{"type":"electronic","value":"1432-1076"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"0024026\/i 08\/05\/2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants and parents included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"157"}}